Cumberland Pharmaceuticals Stock Market Value
| CPIX Stock | USD 1.06 0.02 1.85% |
| Symbol | Cumberland |
Cumberland Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.76) | Revenue Per Share 2.607 | Quarterly Revenue Growth (0.1) | Return On Assets (0.06) | Return On Equity (0.36) |
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cumberland Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cumberland Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cumberland Pharmaceuticals.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Cumberland Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Cumberland Pharmaceuticals or generate 0.0% return on investment in Cumberland Pharmaceuticals over 30 days. Cumberland Pharmaceuticals is related to or competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, Crinetics Pharmaceuticals, Assembly Biosciences, and Instil Bio. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commer... More
Cumberland Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cumberland Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cumberland Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 10.64 | |||
| Value At Risk | (4.69) | |||
| Potential Upside | 3.51 |
Cumberland Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cumberland Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cumberland Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cumberland Pharmaceuticals historical prices to predict the future Cumberland Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.67) |
Cumberland Pharmaceuticals Backtested Returns
Cumberland Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17% return per unit of risk over the last 3 months. Cumberland Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cumberland Pharmaceuticals' Standard Deviation of 2.32, risk adjusted performance of (0.12), and Mean Deviation of 1.79 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cumberland Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cumberland Pharmaceuticals is expected to be smaller as well. At this point, Cumberland Pharmaceuticals has a negative expected return of -0.4%. Please make sure to confirm Cumberland Pharmaceuticals' standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Cumberland Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.05 |
Virtually no predictability
Cumberland Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Cumberland Pharmaceuticals time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cumberland Pharmaceuticals price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Cumberland Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cumberland Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Cumberland Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cumberland Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Cumberland Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Cumberland Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cumberland Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cumberland Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cumberland Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cumberland Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Cumberland Pharmaceuticals Lagged Returns
When evaluating Cumberland Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cumberland Pharmaceuticals stock have on its future price. Cumberland Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cumberland Pharmaceuticals autocorrelation shows the relationship between Cumberland Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Cumberland Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.